BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21269982)

  • 1. [Correlation of the expressions of VEGF-C and VEGFR-3 to the pathological grade of prostate cancer].
    Chen H; Zhao GP; Xiao NX; Xia Q; Lai JS; Zheng DS; Zhao ZH; Xin YH
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):155-9. PubMed ID: 21269982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression.
    Yang J; Wu HF; Qian LX; Zhang W; Hua LX; Yu ML; Wang Z; Xu ZQ; Sui YG; Wang XR
    Asian J Androl; 2006 Mar; 8(2):169-75. PubMed ID: 16491267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of lymphangiogenesis to progression of colorectal cancer].
    Wang TB; Huang YH; Lan P; Song XM; Wang JP
    Ai Zheng; 2005 Oct; 24(10):1276-9. PubMed ID: 16219148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
    Mylona E; Alexandrou P; Mpakali A; Giannopoulou I; Liapis G; Markaki S; Keramopoulos A; Nakopoulou L
    Eur J Surg Oncol; 2007 Apr; 33(3):294-300. PubMed ID: 17129704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR; Min K; Kim HS; Jung WW; Park YK
    Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate.
    Li R; Younes M; Wheeler TM; Scardino P; Ohori M; Frolov A; Ayala G
    Prostate; 2004 Feb; 58(2):193-9. PubMed ID: 14716745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
    Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationships of human laryngeal squamous cell carcinomas with the expression of VEGF-C and VEGFR-3].
    Wang Z; Li R; Zhou B; Liang W; Liang C; Zhang L; Chen Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Aug; 26(4):842-6. PubMed ID: 19813623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
    Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
    Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
    Jennbacken K; Vallbo C; Wang W; Damber JE
    Prostate; 2005 Oct; 65(2):110-6. PubMed ID: 15880525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The expression of VEGF-C, VEGFR-3 and its predictive value on lymph node metastasis and prognosis of gastric cancer].
    Han FH; Zhan WH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
    Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1058-61. PubMed ID: 17074247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.
    Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED
    Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma].
    Zhao GG; Xiang XJ; He YJ
    Ai Zheng; 2007 Jan; 26(1):90-5. PubMed ID: 17222375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face.
    Tokuyama W; Mikami T; Masuzawa M; Okayasu I
    Hum Pathol; 2010 Mar; 41(3):407-14. PubMed ID: 19913279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
    Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
    Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes.
    Mori R; Dorff TB; Xiong S; Tarabolous CJ; Ye W; Groshen S; Danenberg KD; Danenberg PV; Pinski JK
    Prostate; 2010 Nov; 70(15):1692-700. PubMed ID: 20564320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of vascular endothelial growth factor (VEGF)-A and its receptor in clinically localized prostate cancer: a prospective evaluation in 100 patients undergoing radical prostatectomy.
    Mao K; Badoual C; Camparo P; Delongchamps NB; Vieillefond A; Dinh-Xuan AT; Peyromaure M
    Can J Urol; 2008 Oct; 15(5):4257-62. PubMed ID: 18814815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.